Exploring the molecular basis of labile heme as a prothrombotic modulator in hemolytic disorders
Laufzeit: ab 01.03.2022
Förderung durch: Gesellschaft für Thrombose- und Hämostaseforschung e.V. (GTH)
Kurzfassung
The aim of this project is to provide knowledge about the molecular basis of heme-driven effects on factors of the blood coagulation system in the context of prothrombotic complications in patients suffering from hemolytic disorders.
